Literature DB >> 26449186

Photomediated Reactive Oxygen Species-Generable Nanoparticles for Triggered Release and Endo/Lysosomal Escape of Drug upon Attenuated Single Light Irradiation.

Eun Ha Seo1, Chung-Sung Lee1, Kun Na1.   

Abstract

Nanoparticles with "smart" stimuli-responsive materials and multiple therapeutic strategies in a single delivery platform have emerged for highly efficient cancer therapy. Here, photomediated reactive oxygen species (ROS)-generable nanoparticles are designed that can trigger drug release and endo/lysosomal escape upon attenuated single light irradiation, simultaneously, for synergistic chemo-photodynamic ablation. In this study, the self-ROS-generable nanoparticles (SRNs) are prepared from the polymer based on polysaccharide, chlorin e6 as ROS generator and lipoic acid as ROS scavenger covalently conjugated pullulan with anticancer drug (doxorubicin, DOX) through self-assembly, and can disassemble via the ROS-mediated reduction of lipoyl group in response to low level exogenous single light switch. After cellular internalization in hepatic cancer through asialoglycoprotein receptor (ASGPR, as pullulan receptor)-mediated endocytosis, once irradiated, SRNs are able to produce ROS that can simultaneously induce drug release triggering and endo/lysosomal escape of DOX into cytoplasm as well as directly photodynamic therapy for highly efficient chemo-photodynamic cancer therapy. This promising delivery system, which has huge potential in biomedical applications, may be optimal for smart delivery platform.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  drug delivery; endo/lysosomal escape; photodynamic therapy; reactive oxygen species; triggered drug release

Mesh:

Substances:

Year:  2015        PMID: 26449186     DOI: 10.1002/adhm.201500622

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  2 in total

1.  Solubilized chlorin e6-layered double hydroxide complex for anticancer photodynamic therapy.

Authors:  Young-Um Jo; HyunJune Sim; Chung-Sung Lee; Kyoung Sub Kim; Kun Na
Journal:  Biomater Res       Date:  2022-06-11

2.  Treatment of Surgical Brain Injury by Immune Tolerance Induced by Peripheral Intravenous Injection of Biotargeting Nanoparticles Loaded With Brain Antigens.

Authors:  Zhen Tian; Lixia Xu; Qian Chen; Ruoyang Feng; Hao Lu; Huajun Tan; Jianming Kang; Yinsong Wang; Hua Yan
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.